Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
Ancell
anti-CD268 [BAFF-R] (human), mAb (ANC268.2/6E6)
306
CHF
CHF 306.00
In stock
ANC-275-020100 µgCHF 306.00
Product Details | |
---|---|
Synonyms | BAFF-R; BAFF Receptor; BR3; BlySR3; Tumor Necrosis Factor Receptor Superfamily Member 13C; TNFRSF13C |
Product Type | Monoclonal Antibody |
Properties | |
Clone | ANC268.2/6E6 |
Isotype | Mouse IgG1κ |
Immunogen/Antigen | Recombinant human CD268. |
Application |
Flow Cytometry |
Crossreactivity | Human |
Formulation | 50 mM Sodium Phosphate pH 7.5, 100 mM Potassium Chloride, 150mM NaCl, 0.5mg/ml Gentamicin sulfate |
Isotype Negative Control | |
Other Product Data |
Click here for Original Manufacturer Product Datasheet |
Declaration | Manufactured by Ancell Corporation. |
Shipping and Handling | |
Shipping | BLUE ICE |
Short Term Storage | +4°C |
Long Term Storage | +4°C |
Handling Advice | Avoid freeze/thaw cycles. |
Use/Stability | Stable for at least 1 year after receipt when stored at +4°C. |
Documents | |
MSDS | Inquire |
Product Specification Sheet | |
Datasheet | Download PDF |
Description
Three receptors for BAFF were recently identified and designated TACI, BCMA and BAFF-R. BAFF-R signaling is essential for B cell development, survival and humoral immune responses.